ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

In Brief: Let Salaries Rise To Legal Levels, Biomedical Panel Says; Prostatic Cancer Blood Test Found

July 9, 1976

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

“Withheld” News Release On QRA Policies Released

November 11, 1983

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992